Literature DB >> 33457143

Acute Coronary Artery Thrombosis in a Patient With Non-Small Cell Lung Cancer.

Ismahane Lahmidi1, Hanane Aissaoui2, Nabila Ismaili3, Noha Elouafi3.   

Abstract

Patients with cancer are at major risk for both venous and arterial thrombotic complications. Venous involvement of cancer-associated thrombosis encompasses deep vein thrombosis and pulmonary embolism. Arterial manifestations include mainly stroke and myocardial infarction. We present the case of a 59-year-old woman admitted to the hospital for chest pain of five hours duration. She had been diagnosed with advanced lung cancer one month before. Electrocardiogram showed ST-segment elevation in all leads except aVR, suggesting a myocardial infarction. Coronary angiography revealed thrombi in both the right coronary artery and the left anterior descending coronary artery in the absence of any atherosclerotic lesions. Tirofiban infusion was administered; furthermore, a computed tomographic pulmonary angiography showed a distal pulmonary embolism. The patient progressed well and was discharged on anticoagulation with vitamin K antagonist. These findings highly imply that the malignancy altered the patient's blood coagulability and induced the formation of the thrombi ensuing acute myocardial infarction and pulmonary embolism. We will emphasize the relationship between cancer and thrombosis with a special focus on the conservative management strategy with anticoagulant and antiplatelet therapy in acute coronary syndrome without evidence of atherosclerotic lesions.
Copyright © 2021, Lahmidi et al.

Entities:  

Keywords:  acute myocardial infarction; cancer-associated thrombosis; pulmonary embolism

Year:  2021        PMID: 33457143      PMCID: PMC7797464          DOI: 10.7759/cureus.12507

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  9 in total

Review 1.  Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with Cancer.

Authors:  Anna Falanga; Francesca Schieppati; Domenico Russo
Journal:  Semin Thromb Hemost       Date:  2015-09-26       Impact factor: 4.180

Review 2.  The hypercoagulable state of malignancy: pathogenesis and current debate.

Authors:  Graham J Caine; Paul S Stonelake; Gregory Y H Lip; Sean T Kehoe
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

Review 3.  Cancer and coagulation.

Authors:  Alok A Khorana
Journal:  Am J Hematol       Date:  2012-03-03       Impact factor: 10.047

4.  Risk of Arterial Thromboembolism in Patients With Cancer.

Authors:  Babak B Navi; Anne S Reiner; Hooman Kamel; Costantino Iadecola; Peter M Okin; Mitchell S V Elkind; Katherine S Panageas; Lisa M DeAngelis
Journal:  J Am Coll Cardiol       Date:  2017-08-22       Impact factor: 24.094

Review 5.  Thrombosis in cancer: an update on prevention, treatment, and survival benefits of anticoagulants.

Authors:  Agnes Y Y Lee
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2010

6.  Activation of blood coagulation in cancer: Trousseau's syndrome revisited.

Authors:  F R Rickles; R L Edwards
Journal:  Blood       Date:  1983-07       Impact factor: 22.113

7.  Treatment of Venous Thromboembolism in Cancer. Historical Perspective and Evolving Role of the Direct Oral Anticoagulants.

Authors:  Marc Carrier; Gerald Soff; Grégoire Le Gal
Journal:  Cancer Treat Res       Date:  2019

Review 8.  Arterial events in cancer patients-the case of acute coronary thrombosis.

Authors:  Ohad Oren; Joerg Herrmann
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 9.  Epidemiology and pathophysiology of cancer-associated thrombosis.

Authors:  S Noble; J Pasi
Journal:  Br J Cancer       Date:  2010-04-13       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.